KMKenji Matsui

Kenji Matsui

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kenji Matsui has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Shuichiro Yamanaka

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    13 shared publications
  • Takashi Yokoo

    Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of medicine, Tokyo, Japan

    13 shared publications
  • Eiji Kobayashi

    Division of Basic Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi 180-8602, Tokyo, Japan

    10 shared publications
  • Yoshitaka Kinoshita

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    10 shared publications
  • Yuka Inage

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    7 shared publications
  • Kei Matsumoto

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    6 shared publications

Latest Publications

  • Open Access

    Life-supporting functional kidney replacement by integration of embryonic metanephros-bladder composite tissue transplants

    by Yoshitaka Kinoshita, Eiji Kobayashi, Kenji Matsui, Yuka Inage, Keita Morimoto, Shutaro Yamamoto, Satomi Iwai, Kento Kitada, Kentaro Iwasawa, Yatsumu Saito, et al.


  • Open Access

    Caspase 9-induced apoptosis enables efficient fetal cell ablation and disease modeling

    by Kenji Matsui, Masahito Watanabe, Shutaro Yamamoto, Shiho Kawagoe, Takumi Ikeda, Hinari Ohashi, Takafumi Kuroda, Nagisa Koda, Keita Morimoto, Yoshitaka Kinoshita, et al.

    Fetal cell ablation models are crucial for studying congenital diseases, organ regeneration, and xenotransplantation. However, conventional knockout models offer limited control over disease severity, while conditional ablation models often require fetus-harming inducers. In the present study, we demonstrate that the inducible caspase 9 system enables precise targeting of fetal nephron progenitor cells in mice through the intrinsic apoptotic pathway. Using a safe, placenta-permeable inducer, this system facilitates specific, rapid, and efficient cell ablation. The system’s temporal control allows precise adjustment of disease severity, generating reproducible models ranging from congenital kidney deficiency to severe chronic kidney disease. Cells with low expression levels of inducible caspase 9 and those in solid organs are less susceptible to apoptosis. However, this limitation can be overcome by inhibiting the X-linked inhibitor of apoptosis protein, thereby expanding the system’s applicability. Additionally, this model provides a developmental environment suitable for chimeric kidney regeneration. This system advances understanding of induced cell death mechanisms, enhances pathological research tools, and supports therapeutic development in kidney disease and xenotransplantation applications.


  • Open Access

    Fetal-to-fetal kidney transplantation in utero

    by Keita Morimoto, Shuichiro Yamanaka, Kenji Matsui, Yoshitaka Kinoshita, Yuka Inage, Shutaro Yamamoto, Nagisa Koda, Naoto Matsumoto, Yatsumu Saito, Tsuyoshi Takamura, et al.

    Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we develop a unique approach of “transplantation of fetal kidneys from a different species during the fetal stage.” In this study, we first validate the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) are subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys are confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production is sustained. Next, we perform xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero leads to the maturation of renal tissue structures. We demonstrate organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.


  • Open Access

    Application of double filtration plasmapheresis to cynomolgus monkeys: surgical techniques and a pilot study of pig fetal kidney transplantation

    by Genki Watanabe, Maiko Horikawa, Izumi Yamamoto, Tomohisa Endo, Takashi Watanabe, Akinori Hiratsuka, Tsuyoshi Takamura, Kenji Matsui, Naoto Matsumoto, Yatsumu Saito, et al.

    Purpose: To detail a technique to implant a double-lumen catheter to remove anti-pig antibodies. We transplanted fetal pig kidneys into cynomolgus monkeys using a double filtration plasma exchange (DFPP) protocol.


  • Open Access

    Generation of human-pig chimeric renal organoids using iPSC technology

    by Koki Fujimori, Shuichiro Yamanaka, Kentaro Shimada, Kenji Matsui, Shiho Kawagoe, Takao Kuroda, Atsushi Ikeda, Makoto Inoue, Eiji Kobayashi, Takashi Yokoo

    Porcine organs and human induced pluripotent stem cell (iPSC)-derived organoids as alternative organs for human transplantation have garnered attention, but both face technical challenges. Interspecies chimeric organ production using human iPSCs shows promise in overcoming these challenges. Our group successfully generated chimeric renal organoids using human iPSC-derived nephron progenitor cells (NPCs) and fetal mouse kidneys. However, the current technology is limited to rodents. Therefore, this study focused on producing human-pig chimeric renal organoids, as pigs are the most promising species for xenotransplantation. Modification of existing culture systems enables continuous renal development in both species, resulting in the successful creation of human-pig chimeric renal organoids. Moreover, this method can be applied to generate humanized xenogeneic kidneys for future clinical applications. This study provides evidence that optimizing culture conditions enables the early-stage kidney development beyond species barriers, thus laying the foundation for accelerating research on humanized xenogeneic kidney fabrication for clinical purposes.


  • Open Access

    Fetal Kidney Transplantation into In Utero Fetuses

    by Takashi Yokoo, Keita Morimoto, Shuichiro Yamanaka, Kenji Matsui, Yoshitaka Kinoshita, Yuka Inage, Shutaro Yamamoto, Nagisa Koda, Naoto Matsumoto, Yatsumu Saito, et al.

    Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we developed a unique approach of “transplantation of fetal kidneys from a different species during the fetal period.” In this study, we first validated the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) were subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys were confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production was sustained. Next, we performed xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero led to the maturation of renal tissue structures. We demonstrated organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.

  • Open Access

    Fetal Kidney Grafts and Organoids from Microminiature Pigs: Establishing a Protocol for Production and Long-Term Cryopreservation

    by Yuka Inage, Koki Fujimori, Masaki Takasu, Kenji Matsui, Yoshitaka Kinoshita, Keita Morimoto, Nagisa Koda, Shutaro Yamamoto, Kentaro Shimada, Takashi Yokoo, et al.

    Fetal organs and organoids are important tools for studying organ development. Recently, porcine organs have garnered attention as potential organs for xenotransplantation because of their high degree of similarity to human organs. However, to meet the prompt demand for porcine fetal organs by patients and researchers, effective methods for producing, retrieving, and cryopreserving pig fetuses are indispensable. Therefore, in this study, to collect fetuses for kidney extraction, we employed cesarean sections to preserve the survival and fertility of the mother pig and a method for storing fetal kidneys by long-term cryopreservation. Subsequently, we evaluated the utility of these two methods. We confirmed that the kidneys of pig fetuses retrieved by cesarean section that were cryopreserved for an extended period could resume renal growth when grafted into mice and were capable of forming renal organoids. These results demonstrate the usefulness of long-term cryopreserved fetal pig organs and strongly suggest the effectiveness of our comprehensive system of pig fetus retrieval and fetal organ preservation, thereby highlighting its potential as an accelerator of xenotransplantation research and clinical innovation.


  • Open Access

    Exploration of Preservation Methods for Utilizing Porcine Fetal-Organ-Derived Cells in Regenerative Medicine Research

    by Kenji Matsui, Hidekazu Sekine, Jun Ishikawa, Shin Enosawa, Naoto Matsumoto, Yuka Inage, Yoshitaka Kinoshita, Keita Morimoto, Shutaro Yamamoto, Nagisa Koda, et al.

    Human pluripotent stem cells have been employed in generating organoids, yet their immaturity compared to fetal organs and the limited induction of all constituent cell types remain challenges. Porcine fetal progenitor cells have emerged as promising candidates for co-culturing with human progenitor cells in regeneration and xenotransplantation research. This study focused on identifying proper preservation methods for porcine fetal kidneys, hearts, and livers, aiming to optimize their potential as cell sources. Extracted from fetal microminiature pigs, these organs were dissociated before and after cryopreservation–thawing, with subsequent cell quality evaluations. Kidney cells, dissociated and aggregated after vitrification in a whole-organ form, were successfully differentiated into glomeruli and tubules in vivo. In contrast, freezing hearts and livers before dissociation yielded suboptimal results. Heart cells, frozen after dissociation, exhibited pulsating heart muscle cells similar to non-frozen hearts. As for liver cells, we developed a direct tissue perfusion technique and successfully obtained highly viable liver parenchymal cells. Freezing dissociated liver cells, although inferior to their non-frozen counterparts, maintained the ability for colony formation. The findings of this study provide valuable insights into suitable preservation methods for porcine fetal cells from kidneys, hearts, and livers, contributing to the advancement of regeneration and xenotransplantation research.


  • Open Access

    Maturation and development of fetal pig intestinal tissue in immunodeficient mice

    by Atsushi Harada, Naoto Matsumoto, Yoshitaka Kinoshita, Kenji Matsu, Yuka Inage, Keita Morimoto, Shuichiro Yamanaka, Masashi Kurobe, Takashi Yokoo, Haruki Kume, et al.

    This study aimed to compare the degree of maturation and development of fetal pig segmental intestinal tissue with that of spheroids created by in-vitro reaggregation of dissociated fetal intestinal cells after transplantation into immunodeficient mice.